Hemostatic abnormalities may predict chronic hypertension after preeclampsia

Gynecologic and Obstetric Investigation

Volumn 41, Issue 1, 1996, Pages 20-26

  Bremme, Katarina ^a   Blombäck, Margareta ^b  

^a Department of Woman and Child Health   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Chronic hypertension; Factor VII; Fibrinogen; Plasminogen activator inhibitor 1; Preeclampsia; Thrombin markers

Indexed keywords

ANTITHROMBIN; BLOOD CLOTTING FACTOR 7; BLOOD CLOTTING INHIBITOR; FIBRINOGEN; MARKER; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTEIN C; PROTEIN S; PROTHROMBIN; THROMBIN;

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; ESSENTIAL HYPERTENSION; FEMALE; FOLLOW UP; HEMOSTASIS; HUMAN; PREDICTION; PREECLAMPSIA; PRIORITY JOURNAL; RISK;

EID: 0030071665     PISSN: 03787346     EISSN: 1423002X     Source Type: Journal    
DOI: 10.1159/000292029     Document Type: Article

References (33)

1. Meade TW, Miller GJ, Rosenberg RD: Characteristics associated with the risk of arterial thrombosis and the prethrombotic state; in Fuster V, Verstraete M (eds): Thrombosis in Cardiovascular Disorders. Philadelphia, Saunders, 1992, pp 79-97.
2. Hamsten A, Wiman B, de Fairc U, Blomback M: Increased plasma levels of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction. N Engl J Med 1985;313:1557-1563.
3. Chesley LC: Hypertension in pregnancy: Definitions. familial factors and remote prognosis. Kidney Int 1980:19:234-240.
4. Davey DA, MacGillivray I: Hypertension in pregnancy; in Sharp F, Symonds EM (eds): Proceedings of the Sixteenth Study Group of the Royal College of Obstetricians and Gynaecologists, 1986. New York. Perinatology Press, 1987.
5. Vermylen C, de Vreker RA, Verstraete M: A rapid enzymatic method for assay of fibrinogen fibrin polymerization time (FPT) test. Clin Chim Acta 1963:8:418-424.
6. Odegaard OR, Try K, Andersson TR: Protein C: An automated activity assay. Haemostasis 1987;17:109-113.
7. Abildgaard U, Lie M, Odegaard OR: Antithrombin heparin co-factor assay with new chromogenic substrates S-2238 and Chromo-zyn TH. Thromb Res 1977;11:549-553.
8. Oswaldsson U, Wilson S, Rosen S: A simple chromogenic assay for the determination of factor VII in microtiter plates (abstract 153). Thromb Haemost 1985;54:26.
9. Chmielewska J, Wiman B: Determination of tissue plasminogen activator and its ‘fast’ inhibitor in plasma. Clin Chem 1986:32:482-485.
10. Wiman B, Ranby M: Determination of soluble fibrin in plasma by a rapid and quantitative spectrophotometric assay. Thromb Haemost 1986;55:189-193.
11. Lecander I, Astedt B: Isolation of a new specific plasminogen activator inhibitor from pregnancy plasma. Br J Haematol 1986;62:221-228.
12. Pclzer H, Schwarz A, Heimburger N: Determination of human thrombin-antithrombin III complex in plasma with enzyme-linked immunosorbent assay. Thromb Haemost 1988:59: 101-106.
13. Pelzer H, Schwartz A, Stuber W: Determination of human prothrombin activation fragment 1+2 in plasma with an antibody against a svnthetic peptide. Thromb Haemost 1991:65: 153-159.
14. Elms MJ, Buncc IH, Bundcsen PG, Rylatt DB, Webber AJ, Masci PP, Whitaker AN: Measurement of cross-linked fibrin degradation products, an immunoassay using monoclonal antibodies. Thromb Haemost 1983;50:591-594.
15. Malm J, Laurell M, Dahlbäck B: Changes in the plasma levels of vitamin K-dependent protein C and S and of C4b binding protein during pregnancy and oral contraception. Br J Haematol 1988;68:437-443.
16. Harris EN, Gharavi AE, Boey ML, Patel BM, MacWorth-Young CG, Loizou S, Hughers GRV: Anticardiolipin antibodies: Detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus. Lancet 1983;Vol ii: 1211-1213.
17. Lindheimer MD, Katz AI: Current concepts: Hypertension in pregnancy. N Engl J Med 1985;313:675-680.
18. Amgrimsson R, Bjömsson S, Geirsson RT, Björnsson H, Walker JJ, Snaeda G: Genetic and familial predisposition to eclampsia and pre-eclampsia in a defined population. Br J Obstet Gynaecol 1990;97:762-769.
19. Brcmmc K, Östlund E, Almqvist I, Heinonen K, Blombäck M: Enhanced thrombin generation and fibrinolytic activity in normal preg-nancv and pucrperium. Obstet Gvnecol 1992; 80:132-137.
20. Moor E, Silveira A, van’t Hooff F, Suontaka A-M, Eriksson P. Blomback M, Hamsten A: Coagulation factor VII mass and activity in young men with myocardial infarction at a young age: Role of plasma lipoproteins and factor VII genotype. Artcriosclcr Thromb Vase Biol 1995;15:655-664.
21. Bremme K, Wramsby H. Andersson O, Wallin M, Blombäck M: Do lowered factor VII levels at extremely high endogenous oestradiol levels protect against thrombin formation? Blood Coagul Fibrinolysis 1994:5:205-210.
22. Landin K, Tengborn L, Smith U: Elevated fibrinogen and plasminogen activator inhibitor (PAI-1) in hypertension are related to metabolic risk factors for cardiovascular disease. J Intern Med 1990:227:273-278.
23. Meade TW, Cooper J, Miller GJ, Howarth DJ, Stirling Y: Antithrombin III and arterial disease. Lancet 1991;337:8504.
24. Cignetti M, Garzctti GG, Marchegiani F, Fa-bris N, Romanini C: Natural killer cells and Tac antigen in the hypertension of pregnancy. Clin Exp Obstet Gynecol 1990;17:13-15.
25. Greer IA, Haddad NG, Dawes J, Johnstone FD, Calder AA: Neutrophil activation in pregnancy induced hypertension. Br J Obstet Gynaecol 1989:96:978-982.
26. Lechner K: Lupus anticoagulants and thrombosis; in Verstraete M. Vermylen J, Lijnen HR. Arnout J (eds): Thrombosis and Haemostasis. Leuven, University Press, 1987, pp 525-547.
27. Hamsten A, Norberg R, Björkholm M, de Faire U, Holm G: Antibodies to cardiolipin in young survivors of myocardial infarction: An association with recurrent cardiovascular events. Lancet 1986;Vol i:11311-11316.
28. Morton KE, Gavaghan TP, Krilis SA, Daggard GE, Baron DW, Hickie JB, Chesterman CN: Coronary' artery bypass graft failure: An auto immune phenomenon? Lancet 1986;Vol i: 1353-1357.
29. Lockwood CJ, Romero R, Feinberg RF, Clyne LP. Coster B, Hobbins JC: The prevalence and biologic significance of lupus anticoagulant and anticardiolipin antibodies in a general obstetric population. Am J Obstet Gynecol 1989:161: 369-373.
30. Bredbacka S, Blombäck M, Wiman B, Pelzer H: Disseminated intravascular coagulation in neurosurgical patients: Diagnosis by new laboratory methods. J Neurosurg Anesthesiol 1992; 4:128-133.
31. Stirling Y, Woolf WRS, Seghatchian NMJ, Meade TW; Haemostasis in normal pregnancy. Thromb Haemost 1984:52:176-182.
32. Dahlman T, Hellgren M, Blombäck M: Changes in blood coagulation and fibrinolysis in the normal puerperium. Gynecol Obstet Invest 1985;20:37-44.
33. Deng L, Bremme K, Hansson LO, Blombäck M: Plasma levels of von Willebrand factor and fibronectin as markers of persisting endothelial damage in preeclampsia. Obstet Gynecol 1994; 84:941-945.